Could a cell transplant ease advanced Parkinson's? new trial begins
NCT ID NCT07102342
First seen Mar 21, 2026 · Last updated May 22, 2026 · Updated 8 times
Summary
This early-stage trial tests a new treatment called NouvNeu001 in 5 people with advanced Parkinson's disease. The goal is to see if it is safe and if it can improve movement and other symptoms. Participants receive a transplant of special cells and are followed for up to 96 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cornell University Weill Medical College
RECRUITINGNew York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.